
Sign up to save your podcasts
Or


Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”.
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.
By The Economist4.3
37633,763 ratings
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”.
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.

7,865 Listeners

927 Listeners

296 Listeners

588 Listeners

365 Listeners

98 Listeners

109 Listeners

665 Listeners

237 Listeners

2,568 Listeners

47 Listeners

1,089 Listeners

1,411 Listeners

151 Listeners

115 Listeners

102 Listeners

37 Listeners

491 Listeners

893 Listeners

372 Listeners

497 Listeners

82 Listeners

192 Listeners

147 Listeners

72 Listeners

100 Listeners

263 Listeners